Alkylphenols perturb the endocrine system and are considered to have weak estrogenic activities. Although it is known that nonylphenol can bind weakly to the estrogen receptor, it is unclear whether all reported effects of nonylphenol are attributable to its estrogen receptor-binding activity. In order to examine whether alkylphenols have similar effects to the natural hormone, estradiol, we used a mouse model to examine the effects of nonylphenol on gene expression and compared it with estradiol. DNA microarray analysis revealed that, in the uterus, most of the genes activated by this alkylphenol at a high dose (50 mg/kg) were also activated by estradiol. At lower doses, nonylphenol (0·5 mg/kg and 5 mg/kg) had little effect on the genes that were activated by estradiol. Thus, we concluded that the effects of nonylphenol at a high dose (50 mg/kg) were very similar to estradiol in uterine tissue. Moreover, since evaluation of estrogenic activity by gene expression levels was comparable with the uterotrophic assay, it indicated that analysis of gene expression profiles can predict the estrogenic activities of chemicals. In contrast to the similar effects of nonylphenol and estradiol observed in the uterus, in the liver, gene expression was more markedly affected by nonylphenol than by estradiol. This indicated that, in the liver, nonylphenol could activate another set of genes that are distinct from estrogen-responsive genes. These results indicated that nonylphenol has very similar effects to estradiol on gene expression in uterine but not in liver tissue, indicating that tissue-specific effects should be considered in order to elucidate the distinct effects of alkylphenols.
Introduction
There has recently been considerable concern about the potential endocrine-disrupting effects of chemicals released into the environment. Those chemicals that have estrogenic activity are termed xenoestrogens or endocrine disruptors. They are thought to mimic or disturb the function of estrogen and many are known to possess estrogen receptor-binding activity (Danzo 1997) . Among the xenoestrogens, alkylphenols have been recognized to bind to estrogen receptors and exert weak estrogenic activities in vivo and in vitro (Mueller & Kim 1978 , White et al. 1994 . The estrogenic activity of alkylphenol compounds has been reported not only in laboratory-based studies (Soto et al. 1991 , Shelby et al. 1996 , but also in wildlife (Tyler et al. 1998) , especially fish (Flouriot et al. 1995 , Sumpter & Jobling 1995 .
Since the original discovery of the estrogenic activity of alkylphenols, many further studies have reported diverse adverse effects of these compounds. For example, in animals exposed to nonylphenol, the weight of the epididymis was decreased (Hossaini et al. 2001) , sperm function was affected (Chapin et al. 1999 , Adeoya-Osiguwa et al. 2003 and deleterious effects on mammary gland and uterine function were observed (Odum et al. 1999 , Danzo et al. 2002 .
Despite these studies, the precise mechanisms underlying the adverse effects of endocrinedisrupting chemicals are poorly understood.
Although it is well established that nonylphenol binds the estrogen receptor, it is not certain that all effects of nonylphenol can be explained by this binding activity. To determine whether the diverse effects of nonylphenol are wholly attributable to its estrogen receptor-binding activity, it is essential to compare nonylphenol and estradiol with respect to gene activation. Thus, we here analyzed gene expression patterns caused by nonylphenol and estradiol using microarray technology.
Materials and methods

Animals
Animals were housed under a 12 h light:12 h darkness cycle. ER knockout ( ERKO) mice (Lubahn et al. 1993) and their wild-type counterparts (C57/BL6/J background) were ovariectomized at 8 weeks of age. After 2 weeks, the ovariectomized mice were injected intraperitoneally with a chemical or sesame oil (Nakarai Tesque, Kyoto, Japan) as a vehicle control and whole uteri (n=4) were collected 6 h after dosage. Doses of estrogens used were: 50 µg/kg body weight (BW); 5 µg/kg BW; 0·5 µg/kg BW; and 0·05 µg/kg BW for 17 -estradiol (Sigma, SigmaAldrich Japan, Tokyo, Japan) and 50 mg/kg BW; 5 mg/kg BW; and 0·5 mg/kg BW for nonylphenol (Nakarai Tesque). For the uterotrophic assay, ovariectomized mice were injected intraperitoneally with estrogen or sesame oil every 24 h for 7 days and whole uteri (n=5) were collected and weighed 6 h after the last dosage. The tissues were then fixed in formalin, embedded in paraffin, cut into 8 µm sections and the number of glands was counted. All animal experiments were approved by the institutional Animal Care Committee.
DNA microarray analysis
Total uterine RNA was extracted using TRIZOL (Invitrogen, Tokyo, Japan) and purified using an RNeasy mini kit (Qiagen, Tokyo, Japan). Purified RNA was labeled with biotin according to the manufacturer's protocol and hybridized with a mouse genome U74Av2 array (Affymetrix Japan, Tokyo, Japan). After washing, the array was scanned to measure fluorescent intensity that is representative of gene expression.
The fluorescent intensity of each probe was further analyzed by dChip, a model-based expression analysis program (Baccarelli et al. 2002) and expression levels were estimated. For the analysis, a perfect match (PM)-only model (Baccarelli et al. 2002) was used. The estimated values (gene expression levels) were transferred to the GeneSpring software program (Silicon Genetics, Redwood City, CA, USA) and analyzed. To deduce credible gene expression levels from DNA microarray analysis, we independently repeated each experiment at least twice, with averaged values being used for the analysis.
For the clustering analysis, genes whose expression levels exceeded 1000 were selected and similarities between experiments and genes were measured by standard correlation using the GeneSpring program. After selecting the genes that were activated more than twofold by nonylphenol, k-means analysis was performed using the GeneSpring program beginning from five random starting clusters.
Quantitative real-time PCR
Total RNA was purified as described above. cDNA was synthesized from purified total RNA by Superscript II RT( ) (Invitrogen) with random primers at 42 C for 60 min. PCR reactions were performed in the PE Prism 5700 sequence detector (PE Biosystems, Tokyo, Japan) using SYBR-Green PCR core reagents (PE Biosystems) in the presence of appropriate primers according to the manufacturer's instructions. Each PCR amplification was performed in triplicate under the following conditions: 2 min at 50 C and 10 min at 95 C, followed by a total of 40 two temperature cycles (15 s at 95 C and 1 min at 60 C).
Gene expression levels were normalized to the expression levels of L8 mRNA (U67771) and gel electrophoresis and melting curve analyses were performed to confirm correct amplicon size and the absence of non-specific bands.
The primers were chosen to amplify short PCR products of less than 100 base pairs and their sequences are as follows. X79003 (integrin 5), CCCGAAGAGCCAGTCCAAT, CCCAGCCC TCAGCACCTT; L32752 (Ran GTPase), TTG GAGTTCGTTGCCATGC, ACTGTGCTGCCA AAGCTGG; L40406 (hsp-E7I), GGAACGACC GAAAGTGTTGG, CCTCTGAAGTCCGCTG CAAT; U90446 (RNAse L inhibitor), GAGCAAC CAAGGACAACCTAAAAC, TGCTATTTCCC TGCACTCACTG; Z18272 (collagen 2 type VI), CCATTGCCTGTGACAAGCC, CTCGGACA CCAGGTCAGAGAA; AF000236 (orphan chemokine receptor), AGGACCGGATGTCTCTCC ATT, GTTGATGAGCTCTGTTGATTGACG; U67771 (ribosome L8) ACAGAGCCGTTGTTGG TGTTG, CAGCAGTTCCTCTTTGCCTTGT.
Results
Reproducibility of the DNA microarray analysis
In order to compare the changes in gene expression caused by nonylphenol and estradiol, we administered either agent to mice and examined gene expression profiles by DNA microarray analysis. The reproducibility of the experiments was evaluated by calculating correlation coefficients between experiments under the same conditions as shown in Table 1 . As all combinations of experiments for the same condition had a correlation coefficient of at least 0·9, our DNA microarray data was highly reproducible.
Dose-dependent gene activation by estradiol and nonylphenol
In response to increasing amounts of nonylphenol or estradiol, gene expression levels changed significantly (Fig. 1 ). The r 2 value calculated between treated and control gene expression levels changed dose dependently with increasing doses of estradiol ( Table 2 ), but that of nonylphenol was lower at 0·5 than at 5 mg/kg. In agreement with these r 2 values, gene expression was modulated more significantly at 0·5 mg/kg nonylphenol than at 5 mg/kg nonylphenol. As the number of genes activated by nonylphenol at the highest dose (50 mg/kg) (307 genes) was greater than for estradiol (238 genes; Table 2 ), we examined its influence on the gene expression pattern in more detail.
Evaluation of relative estrogenic activity of nonylphenol from gene expression patterns
To examine whether the genes activated by nonylphenol were similar to those activated by estradiol, we selected 307 genes that were induced more than twofold at the highest dose of nonylphenol (Table 2 ) and performed hierarchal clustering analysis. As shown in the dendrogram (Fig. 2) , the expression pattern caused by the highest dose of nonylphenol was equivalent to that observed between 5 and 0·5 µg/kg estradiol. Although one cluster of genes had a dosedependent gene activation pattern (Fig. 2) , the other cluster showed no prominent dose-dependent gene activation.
Genes activated by nonylphenol are also activated by estradiol
As clustering analysis indicated that the gene activation patterns of nonylphenol and estradiol were similar, we further examined whether the genes activated by nonylphenol were the same as those activated by estradiol. We applied the k-means method to the selected 307 genes to determine if they were also activated by estradiol. If some genes were activated only by nonylphenol, the presence of a cluster that was activated by nonylphenol, but not by estradiol, could be expected. However, even when we increased the number of clusters, we could not identify any cluster that clearly indicated the presence of genes activated by nonylphenol but not estradiol. Figure  3 shows the result of clustering using three clusters. Among the three gene clusters, two clusters ( Fig.  3B-C) showed a rather similar pattern. They were activated by estradiol in a dose-dependent manner and activated by nonylphenol only at the highest dose but exhibited no clear dose-dependent pattern in response to nonylphenol. One cluster (Fig. 3A) showed an atypical pattern compared with the other clusters, with those genes being activated more markedly at the highest dose of nonylphenol. Importantly, dose-dependent gene activation by estradiol correlated with uterotrophic effects, as shown in Fig. 3D . These results indicated that estrogenic activities of nonylphenol can also be estimated by gene expression profiling. The total number of genes activated more than twofold by nonylphenol (307 genes) was greater than that for estradiol (238 genes). These genes were mainly contained within one cluster (Fig. 3A and data not shown), but they were not nonylphenol specific because they were also activated by estradiol, albeit with weaker effects. As shown in Fig. 3 , almost all genes that were activated by the high dose of Number of genes that were activated more than twofold (FC .2) or repressed more than twofold (FC ,0·5) are indicated. Equations of regression lines were calculated from scatter plots in Fig. 1 (treated vs control) and r 2 values were calculated.
nonylphenol or by estradiol were not activated in ERKO mice. Thus, those genes that were upregulated by both nonylphenol and estradiol were activated by the estrogen receptor, either directly or indirectly. These similar gene activation patterns were confirmed by quantitative real-time PCR (Fig. 4) .
Gene activation profile of nonylphenol in liver
As our results in the uterus suggested that nonylphenol and estradiol have similar effects on gene expression, at least at some doses, we examined whether the effects of these chemicals were also similar in another tissue, liver, again using DNA microarrays. As 5 µg/kg estradiol and 50 mg/kg nonylphenol could activate gene expression to similar extents in the uterus ( Fig. 5A and C) , we administered these doses and examined resultant changes in liver gene expression. This indicated that in liver, nonylphenol activated more genes than estradiol ( Fig. 5B and C) . Calculation of fold change of each gene by estradiol or nonylphenol indicated that in liver, gene activation induced by nonylphenol was different from that induced by estradiol (Fig. 5C ). The list of the genes that were activated more markedly by nonylphenol than by estradiol is shown in Table 3 . Overall, our results indicated that nonylphenol and estradiol similarly affect uterine gene expression but have different effects on liver gene expression.
Discussion
In this study, we examined whether nonylphenol has effects on gene expression that are distinct from estrogenic effects, by comparing its effects on gene expression with those of estradiol. Several doses were used since comparison of changes in gene expression at one dose cannot be used to validly estimate the activities of chemicals (Watanabe et al. 2003) . In summary, we demonstrated that (1) the estrogenic activity of nonylphenol could be estimated from gene expression profiling, and this was comparable with results obtained in the uterotrophic assay; (2) almost all genes activated by estradiol in the uterus were also activated by nonylphenol at a high dose; and (3) nonylphenol and estradiol have similar effects on gene expression in the uterus, but not in the liver. Our clustering analysis indicated that the relative activity of nonylphenol estimated from gene expression levels was between 0·001 and 0·0001 (relative to an activity of estradiol equal to 100) (Fig. 2) , which was consistent with the value of 0·00036 estimated in a previous study (Coldham et al. 1997) . This value was also consistent with previous estimations using the uterotrophic assay and other studies using other systems such as E-screen (Soto et al. 1995 , Kwack et al. 2002 , a yeast reporter system (Coldham et al. 1997 , Andersen et al. 1999 ) and a ligand-binding assay (Coldham et al. 1997 , Andersen et al. 1999 .
Our analysis also found that lower doses of nonylphenol did not exhibit estrogenic effects on gene expression. Although genes were activated in a dose-dependent manner by estradiol in three orders of magnitude (0·5-50 µg/kg), they were activated by only one dose (50 mg/kg) of nonylphenol and there was no clear dose-response by nonylphenol. This is clearly illustrated in Fig. 2 where a mid-range dose of nonylphenol (5 mg/kg) is not positioned between 5 µg/kg and 0·5 µg/kg estradiol. Although k-means analysis indicated subsets of genes that were activated at 0·5 mg/kg nonylphenol, this activation pattern was distinct from the effects of estradiol, as indicated in Fig. 3 . This indicated that the effect of nonylphenol at lower doses is not due to the general estrogenic activity of the chemical and that nonylphenol has estrogenic effects only at the highest dose.
In addition to the above findings, another important finding in this study was that the difference in gene activation profiles between nonylphenol and estradiol was much greater in the liver than in the uterus. Nonylphenol-specific changes in gene expression were not prominent in the uterus, whereas in the liver the number of nonylphenol-activated genes was very different from that of estradiol, indicating that their effects on gene expression are tissue specific. This indicated that evaluations of chemical activities which rely on one cell line may be insufficient for validation, and the use of tissues may be critical in order to fully understand the chemical effects.
With regard to the genes that were activated by nonylphenol but not by estradiol in the liver, many genes involved in lipid or fatty acid metabolism were detected in addition to cytochrome P450 genes. These included apolipoprotein A-IV, peroxiredoxin, granulin and lecithin cholesterol acyltransferase, which are involved in lipid metabolism, and acetyl-CoA acyltransferase, which is involved in the metabolism of fatty acids. In rodents, it has been The genes with GeneBank accession numbers that were activated more than fourfold by nonylphenol are indicated with fold changes. Fold changes (log2) calculated from the ratio of gene expression levels of nonylphenol (NP) to those of the control (oil) are indicated in the second column. Fold changes (log2) calculated from the ratio of gene expression levels of estradiol (E2) to those of the control (oil) are indicated in the third column.
